Nipradilol inhibits atmospheric pressure-induced cell proliferation in human aortic smooth muscle cells

Pharmacological Research

Volumn 49, Issue 3, 2004, Pages 217-225

  Iizuka, Kenji ^a   Morita, Noriteru ^a   Murakami, Takeshi ^a   Kawaguchi, Hideaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ERKs; HASMC; Nipradilol; NO; Pressure stress

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NIPRADILOL; NITRIC OXIDE;

AORTA; ARTICLE; ATMOSPHERIC PRESSURE; CELL COMMUNICATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTENSION; INHIBITION KINETICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0347951067     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.09.011     Document Type: Article

References (34)

1. Myers P.R., Minor R.L. Jr., Guerra R. Jr. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 345:1990;161-163.
2. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75:1995;519-560.
3. Nabel E.G. Biology of the impaired endothelium. Am. J. Cardiol. 68:1991;6C-8C.
4. Chiu J.J., Wung B.S., Hsieh H.J., Lo L.W., Wang D.L. Nitric oxide regulates shear stress-induced early growth response. 1. Expression via the extracellular signal-regulated kinase pathway in endothelial cells. Circ. Res. 85:1999;238-246.
5. Napoli C., Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide. 5:2001;88-97.
6. Uchida Y., Nakamura M., Shimizu S.et al. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3- isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Arch. Int. Pharmacodyn. Ther. 262:1983;132-149.
7. Kosegawa I., Inaba M., Morita T.et al. Effect of the vasodilatory beta-blocker, nipradilol, and Ca-antagonist, barnidipine, on insulin sensitivity in patients with essential hypertension. Clin. Exp. Hypertens. 20:1998;751-761.
8. Sonoki H., Nakamura M., Takeshita A. Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats. Heart Vessels. 12:1997;19-26.
9. Nitta K., Tsutsui T., Uchida K.et al. Nipradilol inhibits DNA synthesis by regulating nitric oxide synthesis in cultured rat mesangial cells. Eur. J. Pharmacol. 344:1998;107-111.
10. Horimoto H., Saltman A.E., Gaudette G.R.et al. Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function. Ann. Thorac. Surg. 68:1999;844-849.
11. Ozaki T., Iizuka K., Suzuki M.et al. Threshold-dependent DNA synthesis by pure pressure in human aortic smooth muscle cells: Giα-dependent and -independent pathways. Biochem. Biophys. Res. Commun. 256:1999;212-217.
12. 15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
13. Ishiyama M., Miyazono Y., Sasamoto K.et al. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 44:1997;1299-1305.
14. Lowry O.H., Rosebrough N.J., Farr A.L.et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
15. Tseng H., Peterson T.E., Berk B.C. Fluid shear stress stimulates mitogen-activated protein kinase in endothelial cells. Circ. Res. 77:1995;869-878.
16. Pyles J.M., March K.L., Franklin M.et al. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ. Res. 81:1997;904-910.
17. Iizuka K., Murakami T., Kawaguchi H. Pure atmospheric pressure promotes an expression of osteopontin in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 283:2001;493-498.
18. Abe S., Nakamura M., Kanaide H. Some effects of nipradilol, a beta-antagonist possessing a nitroxy group, on smooth muscle of the pig coronary artery. Br J. Pharmacol. 117:1996;1707-1715.
19. Brehm B.R., Wolf S.C., Bertsch D.et al. Effect of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells. Cardiovasc. Res. 49:2001;430-439.
20. Adachi T., Hori S., Miyazaki K.et al. Ogawa S, Rapid increase in plasma nitrite concentration following intravenous administration of nipradilol. Eur. J. Pharmacol. 286:1995;201-204.
21. Horimoto H., Saltman A.E., Gaudette G.R., Krukenkamp I.B. Nitric oxide-generating β-adrenergic blocker nipradilol preserves postischemic cardiac function. Ann. Thorac. Surg. 68:1999;844-849.
22. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1989;1774-1777.
23. Yu S.M., Hung L.M., Lin C.C. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation. 95:1997;1269-1277.
24. Suhasini M., Li H., Lohmann S.M.et al. Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway. Mol. Cell. Biol. 18:1998;6983-6994.
25. Mitani Y., Zaidi S.H., Dufourcq P.et al. Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning. FASEB. 14:2000;805-814.
26. Ingram A.J., James L., Cai L.et al. NO inhibits stretch-induced MAPK activity by cytoskeletal disruption. J. Biol. Chem. 275:2000;40301-40306.
27. Ishida A., Sasaguri T., Kosaka C.et al. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J. Biol. Chem. 272:1997;10050-10057.
28. John S., Schmieder R.E. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J. Hypertens. 18:2000;363-374.
29. Gosgnach W., Messika-Zeitoun D., Gonzalez W.et al. Shear stress induces iNOS expression in cultured smooth muscle cells: role of oxidative stress. Am. J. Physiol. Cell Physiol. 279:2000;C1880-C1888.
30. Ingram A.J., James L., Ly H.et al. Nitric oxide modulates strech activation of mitogen-activated protein kinases in mesangial cells. Kidney Int. 58:2000;1067-1077.
31. Kanno M., Araie M., Koibuchi H.et al. Effects of topical nipradilol, a beta blocking reagent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans. Br. J. Ophthalmol. 84:2000;293-299.
32. Sandirasegarane L., Charles R., Bourbon N.et al. NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: implications for vascular growth arrest. Am. J. Physiol. Cell Physiol. 279:2000;C225-C235.
33. Komalavilas P., Shah P.K., Jo H.et al. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274:1999;34301- 34309.
34. Marano G., Palazzesi S., Vergari A.et al. Protection by shear stress from collar-induced intimal thickening: role of nitric oxide. Arterioscler. Thromb. Vasc. Biol. 19:1999;2609-2614.